Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302, and to the Office of Management and Budget, Paperwork Reduction Project (0704-0188), Washington, DC 20503
INTRODUCTION
While smoking cessation has received considerable attention within the military, the use of smokeless tobacco (chewing tobacco and snuff) has not been a focus of medical services or research. Epidemiological data suggest that while smoking has continued to decline both in the general population and within the military, the use of smokeless tobacco products has increased. The primary objective of this research is to develop and evaluate an intervention for smokeless tobacco cessation comprised of proactive recruitment, targeted written and video materials mailed to the participant, and phone call support. The primary hypothesis to be tested is that participants randomized to receive the intervention will quit their tobacco use at a significantly higher rate than participants receiving usual care. Active duty U.S. Armed Forces personnel stationed at military locations that are identified as current ST users when completing their annual preventive oral health assessment will be recruited to participate in a randomized two-group design that compares a brief contact intervention with the usual preventive health care. Follow up assessments by mail at 3-and 6-months after randomization will assess the impact of the program.
BODY
In the third year of our grant, we requested and received approval from the IRB at Brooke Army Medical Center (BAMC), TX, to enroll participants at three Army sites in the Great Plains Medical Region: Ft Leavenworth, KS, Ft Polk, LA, and Ft Sill, OK. In addition, we requested and received approval from the Walter Reed Army Medical Center to enroll participants at two additional Army sites in the North Atlantic Medical Region: Ft Drum, NY in Year-02, and Ft Knox, KY, in Year-03. Approval for our protocol was previously granted (May 11, 2004 ) by the Naval Hospital, which is the IRB of record for the Naval Dental Center Southwest and Camp Pendleton in San Diego. Recruitment has been underway at these Army, Navy, and Marine sites in the third year of our grant. In addition, five additional Air Force sites were approved for participation by the Wilford Hall Medical Center (WHMC) IRB: Robins AFB, GA, Mt Home AFB, ID, Little Rock AFB, AR, Langley AFB, VA, and Nellis AFB, NV. A sixth AFB, Eglin AFB, FL, was approved for participation by the Eglin Medical Center IRB. In total our study is involved with recruiting participants at 21 military bases as listed in the table below.
To optimize enrollment of volunteers into the trial, we visited each new site and conducted orientation and training with the dental clinic providers and staff. It is the providers who are the ones who first approach potential participants with the opportunity to enroll in the study. Across all sites where we are presently recruiting, we have enrolled 667 participants to date. For the 334 participants assigned to the Treatment Group, we have completed approximately 761 telephone counseling calls. We are also in the process of collecting three and six-month follow-up assessments via mail. We use telephone surveys for participants not responding to mailed surveys. To date we have collected 313 three-month follow-up assessments and 233 six-month assessments. We have collected three-month follow-up data from approximately 66% of participants who have reached the three-month follow-up assessment and approximately 67% from participants who have reached the six-month follow-up assessment.
Recruitment of Intervention Sites
Listed below are the Air Force, Army, Navy, and Marine sites that are currently participating in our study. The point of contact (POC) is the person located at the dental clinic who will oversee the project at that site. 
North Atlantic Medical Region Army Sites
The process of gaining IRB approval from the Walter Reed Army Medical Center IRB (WRAMC) for enrollment at Ft Drum was quite protracted, lasting at least 12-months. Once the approval was obtained, we were required to use a much longer enrollment packet, i.e., 10 pages long vs. the 4-page enrollment packet approved for AFBs (under the WHMC, Wright-Patterson, and Eglin IRBs) and Army sites in the Great Plains Region (BAMC IRB). As a consequence, enrollment at Ft Drum has been adversely impacted by the longer enrollment forms. The impact of the consent form on enrollment is discussed further in the Reportable Outcomes Section.
Navy and Marines
The process of gaining IRB approval from the Navy Hospital IRB for enrollment at identified Navy and Marine bases was quite protracted as well, lasting 9-months. Again we were required to use a lengthy enrollment packet, i.e., 8 pages long. Recruitment at these sites has also been negatively impacted by the longer enrollment forms. See Reportable Outcomes Section for further discussion.
Processing Amendments to the Original Study Protocol
It has been necessary in the third year of the study to submit several protocol amendments to the governing IRBs. The principal amendments concerned the posting of flyers to advertise the study at each site, changing the second follow-up assessment from 12 months post enrollment to 6 months, and offering cessation materials to Control Group subjects at the time of the 6-month follow-up assessment. We were able to get expeditious approval of amendments from the WHMC, WrightPatterson, Eglin, and BAMC IRBs for these amendments. However, by contrast, approval by the WRAMC IRB was prolonged and frustrating to investigators because of a lack of responsiveness by WRAMC IRB staff and the seemingly continuous changing of POCs at Walter Reed for processing our amendment requests.
Utilization of Telephone Counseling Guidelines based on Principles of Motivational Interviewing
A crucial part of the intervention in this study is the phone call support given by project phone counselors. We have continued to implement, refine, and monitor the quality of telephone counseling calls that incorporate Motivational Interviewing (MI) techniques to reinforce participants' own motivation for quitting smokeless tobacco. We continue to conduct regular supervision sessions with phone counselors to ensure quality and consistency of counseling calls across counselors and across time.
Utilization of Data Entry/Management System
In this study, data are collected at various points in time at both research sites -Oregon Research Institute (ORI) in Eugene, OR, and Wilford Hall Medical Center (WHMC) in San Antonio, TX. We collect baseline tobacco use data along with consent information from participants at the various dental clinics at the time of participant enrollment. Those data are forwarded by the clinics to ORI for data entry. We collect various data points from participants in the Treatment Group at the time of telephone counseling conducted out of the WHMC research site. We conduct follow-up survey assessments by mail with all participants, in both Treatment and Control Groups, at 3-and 6-months post enrollment and those assessments are both sent and processed at ORI by project staff. If the participant does not respond to requests to complete the mailed survey, we call them to conduct a telephone survey, using the same questions. These calls are primarily made by WHMC project staff.
In order to centralize and effectively manage the myriad data collected at both sites, we have continued in Year-03 to utilize, and in some cases refine, the Electronic Data Management System developed in Year-02. The system is accessible by research staff at WHMC through a virtual private network (VPN) that completely protects participant confidentiality and allows WHMC research staff in Texas to accomplish data entry and updates as needed. In addition to being a repository for collected data, the system also serves a scheduling function. It schedules the dates for the three counseling calls to Treatment participants, as well as dates for follow-up assessments. The evolving database will provide the basis for all data analysis procedures to be conducted at the conclusion of the data collection phase.
The database development, expansion, and shared input by staff at WHMC and ORI are key activities in the project. The data entry is all done at ORI where the enrollment data and all follow-up data are stored in secure files by participant number. However after randomization of the participant is completed, any participant assigned to the Treatment condition will be contacted by phone. All phone contacts are done by phone counselors at WHMC, and the information they collect is input into the database for that participant. The Virtual Private Network connection, which was developed and implemented in Year-02, allows the phone counselor to enter key data for the participant into the database. The counselor can also access the database prior to the call to determine the degree of the participant's readiness to quit, amount of smokeless tobacco (ST) used, and other relevant information to use in their motivational interview phone calls. This same system is used in the scheduling and tracking of the follow-up assessments at 3-and 6-months. . "* Continued to utilize and refine an electronic database accessible to project staff at both the ORI and WHMC research sites for data entry and update. "* Developed and implemented an email prompting system to aid in the prompt completion and return of 3-and 6-month mailed assessments by participants in both conditions.
REPORTABLE OUTCOMES
We are in the process of collecting 3-month follow-up outcome measures. No follow-up reportable outcome evaluations have been conducted to date.
CONCLUSIONS
We are still in the enrollment phase of our study and we have no conclusions to report at this time.
We have experienced significant delays in our project due to difficulties in the IRB review process and the project is 6 to 9 months behind schedule at this time. There are several points to make on the IRB process. First, the lack of coordination and cooperation between IRB's of the different branches of the service has resulted in both delays and frustration. For example, the review by the WRAMC IRB took 6 months to complete and required significant changes in both the Consent and HIPPA forms to nmeet their requirements. It should be noted that the protocol had already been approved by the IRBs at Brooke Army Medical Center ant Ft Detrick. Even after the WRAMC review was completed, the final approval was withheld for some time because our materials and WRAMC approval had to first be forwarded to the Medical Research and Materiel Command at Fort Detrick for another review. The review of the approval done at WRAMC was delayed because even an expedited review of the approved protocol required a staff review and memo to the supervisor at Fort Detrick. This resulted in an additional delay of about 8 weeks. Overall, it took about 10 months to obtain WRAMC IRB approval for a study that had already been approved by Wilford Hall Medical Center, Brooke Army Medical Center, the Oregon Research Institute, and Ft Detrick. Additionally, the consent form for enrollment was lengthened by the WRAMC IRB from 1 to 6 pages. As a reminder, this is a minimal-risk study to help military members quit their use of tobacco.
We also experienced a similar delay in the review by the Navy IRB. The Navy IRB had additional unique requirements for their process and the completion and review of our protocol by the Naval Hospital IRB in San Diego took over 6 months. It has been very frustrating to manage a project when we are confronted by numerous obstacles and delays due to numerous IRB reviews. The lack of coordination and cooperation between IRB's of the different branches of the service is a major impediment to conducting research at multiple sites. It is particularly frustrating to us, since this project is of such minimal risk as to be viewed as exempt by some IRB's. We are simply trying to evaluate whether mailed educational materials and phone call support to active dtay military personnel can aid in their quitting their use of snuff or chewing tobacco. Unfortunately some IRB's have treated this protocol the same way that one might consider an experimental drug trial. In our opinion there is a lack of flexibility among IRB committees to view a protocol as minimal risk and conduct a population study such as we proposed. Both the Army IRB at WRAMC and the Navy IRB had extensive additional text that needed to be added to the Consent and HIPPA forms and this made the enrollment of participants in the study much more difficult than necessary at sites for which they are the governing authority. The very lengthy consent form required by these IRBs has had a significant negative impact on our ability to adequately recruit participants into the study. As an example of this contract the table below compares the enrollment for bases using different consent procedures. In all cases, the longer consent form has proved to be a significant impediment to participation by military personnel.
During the first 9 months of recruitment: We hope that there is some administrative review of the IRB review process and that procedures are put in place that could provide more timely and coordinated review of protoco Is that involve minimal risk. We expect to continue enrollment of participants until at least August 2005 in order to maximize our enrollment of study participants and complete our follow-up assessments within the funding period for the project.
Revised Timeline 
DISSF1,1NATRON
We will be requesting a no-cost extension to our project to complete data analysis and final reports for the project. The timeline below shows our revised schedule and extended enrollment period to August 2005. 
APPENDICES

Statement of Informed Consent: Smokeless Tobacco Use in Military Personnel
This clinic is taking part in a smokeless tobacco research study. If you chew tobacco or use snuff, we would like you to participate in this study. We would like to get as close as possible to 100% of smokeless tobacco users to participate. The purpose of this study is to assess the effectiveness of a brief intervention on smokeless tobacco cessation.
Your participation involves the following: 1) Filling out the attached survey. You do not need to be ready to quit smokeless tobacco to participate. All information collected in this study will be kept confidential. Only research staff will have access to your information. All data will be stored by Oregon Research Institute, and this information will not be available to your dentist, other health care providers, or to anyone in the military.
2) Willingness to be contacted by phone at home or work and be offered a smokeless tobacco cessation program. If you agree to participate, you will be randomly assigned (like the toss of a coin) to the treatment group or the control group. If you are assigned to the treatment group, we will call you to discuss your tobacco use and offer you a cessation program that would help you quit using smokeless tobacco on your own at home. If you are assigned to the control group, you will not receive any phone calls or the cessation program. By agreeing to participate in the study you are not obligated to make a quit attempt even if you are assigned to the treatment group.
3) You will receive two more surveys by mail similar to the one attached, the first in 3 months and the second in 6 months.
Risks The risks involved in participating in this study may include: 1) Loss of confidentiality. We will be getting personal information from you. Your social security number will be used if needed to locate you for follow-up surveys and to document your phone conversations with counselors if you are assigned to the treatment group. There is always the slight possibility that someone who is not authorized might see the personal information that is requested from you. However, it is extremely unlikely that this will occur, and we will take every precaution to assure that your data remain anonymous. 2) Discomfort in discussing your use of tobacco. You may be unaccustomed to talking with someone about your tobacco use. However, our counselors have been extensively trained in this area and will be helpful, courteous, and respectful of your needs. 3) Withdrawal Symptoms. If you quit using smokeless tobacco, you may experience withdrawal symptoms from nicotine cravings such as hunger, anxiety, restlessness, or sleep disturbance. These symptoms are common for persons quitting their addiction to tobacco products. Our counselors have been extensively trained in this area and will be helpful, courteous, and respectful of your needs.
Benefits The benefits of participating in this study are: 1) You could receive a free smokeless tobacco quitting program that may enable you to quit without attending classes or medical appointments. Quitting tobacco may be the most important lifestyle change you can make to improve your health.
2) The information you give us may help other military personnel in the future.
? YES, I am interested in participating in this study. (You do not need to be ready to quit to participate.) By signing below I give my consent for the information I provide on the attached survey to be used by scientists at Oregon Research Institute (Eugene, Oregon). I understand that completing this survey is voluntary, I may choose to skip any question, and that this information will be kept confidential.
I also give my consent to being contacted in the future, possibly offered a smokeless tobacco cessation program, and being sent follow-up surveys in the mail. 
HIPAA AUTHORIZATION TO USE AND DISCLOSE INDIVIDUAL HEALTH INFORMATION FOR RESEARCH PURPOSES
What is an authorization? Federal privacy regulations provide safeguards for privacy, security, and authorized access to your personal health information. The Federal Health Insurance & Portability Act (HIPAA) protects the privacy of your personal health information that [INSERT Dental Clinic NAME HERE] and Oregon Research Institute collect in the course of this research study. The only health information that we will access is what you provide in the attached questionnaire. We WILL NOT obtain any information from your dental or medical records. Health information that identifies you may not be used or disclosed to others for research purposes unless you give written permission in advance. 2. Information to be Used or Disclosed. Your individual health information that may be used or disclosed to conduct the study includes: tobacco use history and demographic information such as age, gender, race, rank, education level, marital status, height, and weight. 
5.
Right to Refuse to Sign this Authorization. You understand that you do not have to sign this Authorization. However, if you do not sign this authorization, you will not be allowed to participate in this research study. Your decision not to sign this Authorization will not affect any other treatment, payment, or enrollment in health plans or eligibility for benefits.
6. Right to Withdraw Authorization. You understand you can change your mind and withdraw this Authorization at any time by sending a written notice to Dr. Herbert Severson, 1715 Franklin Blvd, Eugene, OR 97403 or Lt Col Alan Peterson, 59MDOS/MMCP, Wilford Hall Medical Center, 2200 Bergquist Drive, Suite 1, Lackland Air Force Base, TX 78236 to inform the researcher of your decision. If you withdraw this Authorization, the researcher may only use and disclose individual health information already collected for the study. No additional health information about you will be collected by or disclosed to the researcher for the study.
7. Potential Re-disclosure. Only as spelled out in #4 above, or in emergendes and/or as required by state law (in the case of child/elder abuse or intent to harm self or others) will information disclosed to others include information that could be used to identify you. If your information is re-disclosed by them, it may no longer be protected by HIPAA.
Expiration of Authorization. This authorization does not have an expiration date.
I am the research participant. I have read this information, and I understand I will receive a copy of this Authorization when it has been signed. "N Routine Uses:
The SSN and home address will be used for identification and locating purposes. Information derived from the study will be used "to document the study; implementation of medical programs; adjudication of claims; and for the mandatory reporting of medical conditions as required by law. Information may be furnished to Federal, State and local agencies.
Disclosure:
The furnishing of your SSN and home address is mandatory and necessary to provide identification and to contact you. If future Information Indicates that your health may be adversely affected. Failure to provide the Information may preclude your voluntary participation in this investigational study.
PART AMl) -VOLUNTEER AFFIDAVIT Volunteer Subjects in Approved Department of the Army Research Studies
Volunteers under the provisions of AR 40-38 and AR 70-25 are authorized all necessary medical care for injury or disease which Is the proximate result of their participation in such studies. You are being asked to be in this research study because you answered that you currently use smokeless o-tobacco at your annual dental exam. Your participation is entirely voluntary. Refusal to participate will not Q result in any penalty or loss of benefits to which you are otherwise entitled.
SI0-
"The purpose of this study is to assess the effectiveness of a brief intervention on smokeless tobacco cessation i with military personnel.
•-Other studies have shown that telephone support calls from a trained counselor, together with self-help • cessation materials sent by mail, is very effective in helping smokeless tobacco users to quit. This study is based upon a published study with military personnel that used the same procedures. A study has reported that these procedures have also been effective with civilian smokeless tobacco users.
If you agree to be in this study, you will be asked: (1) to fill out the attached survey. This survey includes W U questions regarding your tobacco and alcohol use as well as your demographics (information such as your .X age, race, education level, and marital status). You do not need to be ready to quit smokeless tobacco to fill out the attached initial survey; (2) to be contacted by phone at home or work and be offered a _ smokeless tobacco cessation program. If you agree to participate by signing this form, you will be randomly . assigned (similar to the flip of a coin) to one of two groups, the Treatment group or the Control group. Your <•FH chances of being assigned to each group are equal. 
SIGNATURE OF VOLUNTEER DATE SIGNATURE OF LEGAL GUARDIAN (If volunteer is
PERMANENT ADDRESS OF VOLUNTEER TYPED NAME OF WITNESS
SIGNATURE OF wITNESAFR 50-" DATE PART 5 -TO BE COMPLETED BY INVESTIGATOR ICont'dl
If you are assigned to the Treatment group, you will receive up to three phone calls. The first call attempt will be made within 1-month upon Oregon Research Institute (ORE, the non-profit research organization conducting this study) receiving the completed enrollment packet (this consent form, the HIPAA authorization form, and the initial survey). Phone counselors, hired and trained by ORI, who have been -textensively trained in the area of smokeless tobacco cessation will be making these calls. In the first call you will be offered a smokeless tobacco cessation program that will be mailed to your home. The program -includes a 25-minute video tape and a self-help cessation manual. Two additional supportive phone calls o will be made to discuss the cessation program, your current tobacco use and how you might apply the 0 ', program to your own use. The second phone call will be attempted beginning 3-weeks following the date ý materials are mailed. The third phone call will be attempted either 2-weeks after the second phone call or 2-days following your quit date, should you choose to set a quit date during the second phone call. Each phone call will last up to 20-minutes and all three phone calls will be completed within 3-months of enrolling in this study. If you are assigned to the Control group, you will not receive any phone calls or the cessation program. By agreeing to participate in the study and completing the initial survey, you are not obligated to make a quit attempt even if you are assigned to the Treatment group.
. Both Treatment and Control groups will be asked to complete and return two more surveys, by mail, the first in 3-months following enrollment and the second in 6-months. These surveys will be mailed to you and will each take 20-minutes to complete. You will be asked to return the completed survey in the provided stamped, addressed envelope. These surveys include questions regarding your health and tobacco use. If you Q are assigned to the Treatment group and have received the video and manual, each of these surveys will also * ask for your feedback about the materials as well as your reaction to the phone counselor.
"Both Treatment and Control group participants in the study who do not return the 3-month survey by mail will be contacted by phone and asked to complete the survey over the phone.
AMOUNT OF TIME FOR YOU TO COMPLETE THIS STUDY Z You will be part of this study for a total of 6-months. The three surveys will take approximately 15-minutes each to complete. If you are assigned to the Treatment group and choose to receive the intervention, you will -receive three phone calls, lasting up to 20-minutes each, a video (25-minutes long) and a manual for viewing.
This study is called a multi-service study because participants will be recruited from dental clinics located at all four US military branches. There will be up to 600 people taking part in this study at Fort Drum. A total "1 of 1,600 people will be in the study from all of the dental clinics involved.
<I 'POSSIBLE RISKS OR DISCOMFORTS FROM BEING IN THIS STUDY 4
The risks involved in participating in this study may include:
(1) Loss of confidentiality. We will be getting personal information from you. Your social security number will be used if needed to locate you for follow-up surveys and to document your phone conversations with counselors if you are assigned to the Treatment group. There is always the slight possibility that someone who is not authorized might see the personal information that is requested from you. However, it is extremely unlikely that this will occur, and we will take every precaution to assure that your information remains confidential. -Z\ (2) Discomfort in discussing your use of tobacco. You may be unaccustomed to talking with someone about -your tobacco use. However, our counselors have been extensively trained in this area and will be helpful, courteous, and respectful of your needs.
There are no other expected risks or discomforts from being in this study.
POSSIBLE BENEFITS OF BEING IN THIS STUDY
The possible benefits to you from being in this study are (a) you could receive a free smokeless tobacco 3:
quitting program that may enable you to quit without attending classes or medical appointments; and (b) •s _ quitting tobacco may be the most important lifestyle change you can make to improve your health. However, no benefit can be guaranteed. The information you give us, whether you are assigned to the Treatment or Control group, will help us compare this program to the options already provided to military personnel to assist them in quitting smokeless tobacco use.
CONFIDENTIALITY (PRIVACY) OF YOUR IDENTITY AND YOUR RESEARCH RECORDS
The principal investigator will keep records of your being in this study. All information collected in this study will be kept confidential. All datafiles will be maintained by Oregon Research Institute in Eugene, Oregon. This information will not be available to your dentist, other health care providers, or to anyone in S the military. These records may be looked at by people from the Walter Reed Department of Clinical %ý Investigation, the Walter Reed Human Use Committee, the Army Clinical Investigation Regulatory Office _. (CIRO), the United States Army Medical Research and Materiel Command (USAMRMC, the sponsor of this -,, study), the Institutional Review Boards (committees that review this research to make sure that it is ethical) -at Wilford Hall Medical Center (a study site), Wright-Patterson Medical Center (a study site), and the Oregon Research Institute, and other government agencies as part of their duties. These duties include "¢ -making sure that research subjects are protected. Confidentiality of your records will be protected to the , I,•i extent possible under existing regulations and laws. Complete confidentiality cannot be promised, S. particularly for military personnel, because information bearing on your health may be required to be p reported to appropriate medical or command authorities. Your name will not appear in any published paper or presentation related to this study.
e-._ Every precaution will be taken to assure that the data files remain confidential. Upon completing this consent form and the initial survey, you will be assigned a personal identification number. The assigned personal "~ identification number will not contain any part of your social security number. The consent and survey will
SIGNATURE OF VOLUNTEER DATE SIGNATURE OF LEGAL GUARDIAN (If volunteer is a minor)
PERMANENT ADDRESS OF VOLUNTEER TYPED NAME O9F WiT
be mailed separately from the dental clinic to the Oregon Research Institute (ORI) in Eugene, Oregon where the data will be entered. The data will be stripped of personal identifiers and will be labeled with only your assigned personal identification number. The master list linking your personal identifying information with your assigned personal identification number will be kept in a separate, password encrypted data file to which only the Principal Investigator at ORI, Dr. Severson, and selected professional staff will have access. This master list will be maintained at OR!. Data files will also be password encrypted. All computer data are o) protected from unauthorized access by industry standard encryption and firewall techniques. All hard copies of data will be kept in locked files. Reports describing the results of this study will in no way reveal your identity. All personnel who have access to your information are instructed not to talk about the study participants publicly by name, and refer to them either by number or first name only. Such procedures are made part of the training and are overemphasized to ensure that these safeguards are maintained. All employees of ORI are asked to sign a Certificate of Confidentiality before being employed with the organization.
3:
This research study meets the confidentiality requirements of the Health Insurance Portability and .
• Accountability Act (HIPAA). A HIPAA authorization form for this study will be provided to you separately, and you will be asked to sign that form.
CONDITIONS UNDER WHICH YOUR TAKING PART IN THIS STUDY MAY BE STOPPED WITHOUT YOUR CONSENT
Your taking part in this study may be stopped without your consent if remaining in the study might be , dangerous or harmful to you. Your taking part in this study may also be stopped without your consent if the military mission requires it, or if you become ineligible for medical care at military hospitals.
ELIGIBILITY AND PAYMENT FOR BEING IN THIS STUDY
S,ý Any active duty military personnel who indicate they are a current smokeless tobacco user is eligible for this J study. You will not receive any payment for being in this study.
Ž•
COMPENSATION TO YOU IF INJURED AND LIMITS TO YOUR MEDICAL CARE
'o Should you be injured as a direct result of being in this study, you will be provided medical care for that -injury at no cost to you. You will not receive any compensation (payment) for injury. You should also o understand that this is not a waiver or release of your legal rights. You should discuss this issue thoroughly with the principal investigator before you enroll in this study. Data will be maintained by ORI for five years after the completion of this research study at which time all documents and data files will be destroyed.
Can I review my own research information?
You may look at your personal research information at any time.
7. Can I cancel this Authorization?
Yes. If you cancel this Authorization and stop taking part in this research study, you will no longer be contacted. You can change your mind and withdraw this Authorization at any time by sending a written notice to Dr. Herbert Severson, 1715 Franklin Blvd, Eugene, OR 97403 to inform the researchers of your decision to withdraw from this study. Once you withdraw from the study, the researchers may only use and disclose individual health information already collected for the study. No additional health information about you will be collected by or disclosed to the researchers for the study. 
